NSC4991
dc.creator | US National Cancer Institute | en_GB |
dc.date.accessioned | 2004-12-13T11:25:24Z | |
dc.date.available | 2004-12-13T11:25:24Z | |
dc.date.created | 2003-02-01 | en_GB |
dc.date.issued | 2004-12-13T11:25:24Z | |
dc.identifier | NSC4991 | en_GB |
dc.identifier.uri | http://www.dspace.cam.ac.uk/handle/1810/6346 | |
dc.format.extent | 5365 bytes | |
dc.format.mimetype | chemical/x-cml | |
dc.language.iso | en_GB | |
dc.publisher | Unilever Center for Molecular Informatics, Cambridge University | en_GB |
dc.title | NSC4991 | en_GB |
dc.title.alternative | Benzoic acid, 2-hydroxy-5-[(4-nitrophenyl)azo]-, monosodium salt (9CI) | en_GB |
dc.title.alternative | C.I. Mordant Orange 1 | en_GB |
dc.title.alternative | C.I. Mordant Orange 1, monosodium salt (8CI) | en_GB |
dc.title.alternative | Mordant Yellow 3R | en_GB |
dc.title.alternative | Salicylic acid, 5-[(p-nitrophenyl)azo]-, monosodium salt | en_GB |
dc.title.alternative | Salicylic acid, 5-[(p-nitrophenyl)azo]-, sodium salt | en_GB |
dc.title.alternative | Sodium p-nitrobenzeneazosalicylate | en_GB |
dc.title.alternative | 5-(p-Nitrophenylazo)salicylic acid sodium salt | en_GB |
dc.type | Chemical Structures | en_GB |
dc.identifier.inchikey | YVJPMMYYRNHJAU-CCEZHUSRSA-N | |
dc.identifier.inchi | InChI=1S/C13H9N3O5/c17-12-6-3-9(7-11(12)13(18)19)15-14-8-1-4-10(5-2-8)16(20)21/h1-7,17H,(H,18,19)/b15-14+ | |
dc.identifier.ichi | C13H9N3O5,17-13(21H)11-7H-9(3H-6H-12(11)20H)15-14-8-1H-4H-10(5H-2H-8)16(18)19 | en_GB |
Files in this item
This item appears in the following Collection(s)
-
WWMM
The WorldWideMolecularMatrix, an Open collection of information on small molecules